Division of Genetic Medicine and Clinical Pharmacology Archive — Page 3 of 12
-
September 27, 2024
Distant relatedness in biobanks harnessed to identify undiagnosed genetic disease
VUMC researchers have developed a genetic method that clusters distantly related people to find rare variants that were present in a common ancestor. -
September 25, 2024
Alexander Bick named head of Genetic Medicine
Bick will succeed Nancy Cox, PhD, who has led Genetic Medicine since she came to VUMC in 2015. Genetic Medicine is one of 13 divisions in the Department of Medicine. -
September 20, 2024
Melinda Aldrich elected to genetics society board of directors
Aldrich uses population-based cohorts and biobanks to investigate lung cancer; her research informed guidelines for lung cancer screening. -
September 9, 2024
Peptide discovery could advance treatment of high blood pressure
VUMC researchers found that peptides modified by highly reactive compounds called isolevuglandins activated T cells and promoted hypertension in mice. Their first-ever isolation of such peptides is a step toward potentially intervening in this pathologic process. -
August 13, 2024
$3.4 million research grant targets risk of heart attack, stroke
Making innovative use of observational data, researchers hope to gain new understanding of patient risk and identify existing drugs to lower risk. -
July 8, 2024
GeneMAP discovery platform will help define functions for ‘orphan’ metabolic proteins
The combination of genomics and metabolism identified a long-sought mitochondrial choline transporter. -
June 4, 2024
Research raises hope for treating potentially lethal blood condition
Roughly 1 in 10 people over age 70 will develop CHIP, an explosive, clonal growth of abnormal blood cells that increases risk of blood cancers and death from cardiovascular, lung and liver disease.